Next Article in Journal
Introduction of Novel Semiquantitative Evaluation of 99mTc-MIBI SPECT Before and After Treatment of Glioma
Previous Article in Journal
Diagnostic Value of Conventional Visual Evoked Potentials Applied to Patients With Multiple Sclerosis
 
 
Medicina is published by MDPI from Volume 54 Issue 1 (2018). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Lithuanian Medical Association, Lithuanian University of Health Sciences, and Vilnius University.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Frequency of HLA-DRB1 Gene Alleles in Patients With Multiple Sclerosis in a Lithuanian Population

by
Renata Balnytė
1,*,
Daiva Rastenytė
1,
Dalia Mickevičienė
1,
Antanas Vaitkus
1,
Erika Skrodenienė
2 and
Astra Vitkauskienė
2
1
Department of Neurology, Medical Academy, Lithuanian University of Health Sciences, Lithuania
2
Department of Laboratory Medicine, Medical Academy, Lithuanian University of Health Sciences, Lithuania
*
Author to whom correspondence should be addressed.
Medicina 2012, 48(1), 2; https://doi.org/10.3390/medicina48010002
Submission received: 10 November 2011 / Accepted: 5 January 2012 / Published: 10 January 2012

Abstract

The aim of the present study was to investigate the influence of HLA-DRB1 alleles on the genetic susceptibility to multiple sclerosis in the Lithuanian population.
Material and Methods
. A total of 120 patients with multiple sclerosis and 120 unrelated healthy controls were enrolled in this case-control study. Allelic frequencies were compared between the groups. HLA-DRB1 alleles were genotyped using the polymerase chain reaction.
Results
. HLA-DRB1*15 was present in 55.8% of the patients with multiple sclerosis and 10.0% of the controls (OR, 5.58; 95% CI, 3.19–9.77; P<0.0001). The protective alleles that were found to be more prevalent among the controls compared with the patients with multiple sclerosis were HLADRB1* 01 (26.7% vs. 7.5%, P<0.0001), *03 (17.5% vs. 8.3%, P=0.034), and *16 (11.7% vs. 3.3%, P=0.014). HLA-DRB1*15 was more common among the female patients with multiple sclerosis than among the male patients (68.4% vs. 34.1%; OR, 4.18; 95%, CI 1.90–9.22; P=0.001). The heterozygous inheritance of HLA-DRB1*15 allele was more common in the patients with a history of maternal multiple sclerosis than in those with a history of paternal multiple sclerosis (29.4% vs. 9.8%; P=0.045).
Conclusions
. HLA-DRB1*15 was found to be associated with multiple sclerosis in the Lithuanian population. This allele was more prevalent among the female patients with multiple sclerosis. Maternal multiple sclerosis was more common than paternal multiple sclerosis, but the relationship with HLA-DRB1*15 allele was not established. HLA-DRB1*01, *03, and *16 appeared to be the protective alleles in this series.
Keywords: multiple sclerosis; human leukocyte antigen; case-control study; heterozygous inheritance; homozygous inheritance multiple sclerosis; human leukocyte antigen; case-control study; heterozygous inheritance; homozygous inheritance

Share and Cite

MDPI and ACS Style

Balnytė, R.; Rastenytė, D.; Mickevičienė, D.; Vaitkus, A.; Skrodenienė, E.; Vitkauskienė, A. Frequency of HLA-DRB1 Gene Alleles in Patients With Multiple Sclerosis in a Lithuanian Population. Medicina 2012, 48, 2. https://doi.org/10.3390/medicina48010002

AMA Style

Balnytė R, Rastenytė D, Mickevičienė D, Vaitkus A, Skrodenienė E, Vitkauskienė A. Frequency of HLA-DRB1 Gene Alleles in Patients With Multiple Sclerosis in a Lithuanian Population. Medicina. 2012; 48(1):2. https://doi.org/10.3390/medicina48010002

Chicago/Turabian Style

Balnytė, Renata, Daiva Rastenytė, Dalia Mickevičienė, Antanas Vaitkus, Erika Skrodenienė, and Astra Vitkauskienė. 2012. "Frequency of HLA-DRB1 Gene Alleles in Patients With Multiple Sclerosis in a Lithuanian Population" Medicina 48, no. 1: 2. https://doi.org/10.3390/medicina48010002

Article Metrics

Back to TopTop